B., Sullivan, D
not recommended for use with DPP-4 inhibitors Common side effects : Gastrointestinal symptoms (nausea, vomiting, diarrhea) that typically diminish with continued use and proper dose titration Referral to endocrinology or obesity medicine specialists is appropriate for complex cases, including patients with multiple failed therapies, significant comorbidities, or those requiring comprehensive weight management programs
Eligibility typically includes the following criteria: A Body Mass Index (BMI) of 27.5 kg/m or higher
Beyond the GLP-1 patch, the company sells other patches aimed at energy, skin health, aging support, focus, and even mosquito protection
Online doctor consult An MOH-licensed doctor reviews your information and builds a personalised care plan
Compare these quality markers across peptide vendor options to make an informed choice